Nano Labs Ltd Files 6-K, Incorporates Exhibit

Ticker: NA · Form: 6-K · Filed: Oct 15, 2025 · CIK: 1872302

Sentiment: neutral

Topics: regulatory-filing, foreign-private-issuer, registration-statement

TL;DR

Nano Labs filed a 6-K on Oct 15, 2025, incorporating an exhibit into its F-3 registration. Standard compliance update.

AI Summary

Nano Labs Ltd filed a Form 6-K on October 15, 2025, incorporating by reference an exhibit (99.1) into its existing F-3 registration statements filed on August 14, 2023. The filing pertains to its status as a foreign private issuer and its reporting obligations under the Securities Exchange Act of 1934.

Why It Matters

This filing indicates ongoing regulatory compliance and updates to registration statements, which can affect investor confidence and the availability of securities for trading.

Risk Assessment

Risk Level: low — This is a routine filing for a foreign private issuer, primarily incorporating an exhibit into existing registration statements, with no immediate indication of significant new risks.

Key Players & Entities

FAQ

What is the primary purpose of this Form 6-K filing by Nano Labs Ltd?

The primary purpose is to report information as a foreign private issuer and to incorporate by reference an exhibit (99.1) into its existing Form F-3 registration statements.

When was the Form 6-K filed?

The Form 6-K was filed on October 15, 2025.

What is the significance of incorporating Exhibit 99.1 into the Form F-3 registration statements?

Incorporating the exhibit means it becomes part of the registration statements, providing updated or supplementary information to investors regarding the securities registered under the F-3.

What is the company's principal executive office address?

The company's principal executive offices are located at China Yuangu Hanggang Technology Building, 509 Qianjiang Road, Shangcheng District, Hangzhou, Zhejiang, 310000, People's Republic of China.

Under which SEC rules is this Form 6-K filed?

This Form 6-K is filed pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934.

Filing Stats: 299 words · 1 min read · ~1 pages · Grade level 11.5 · Accepted 2025-10-15 08:00:20

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Nano Labs Ltd Date: October 15, 2025 By: /s/ Jianping Kong Name: Jianping Kong Title: Chairman and Chief Executive Officer 2 EXHIBIT INDEX Exhibit No. Description 99.1 Press Release 3

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing